RVL Pharmaceuticals plc

Related Filers (33)

Financials (21)

10-Q
Monday, 8/14/2023
Quarterly Report for period ending 2023-06-30
10-Q
Thursday, 5/11/2023
Quarterly Report for period ending 2023-03-31
10-K
Monday, 3/20/2023
Annual Report for period ending 2022-12-31
10-Q
Thursday, 11/10/2022
Quarterly Report for period ending 2022-09-30
10-Q
Thursday, 8/11/2022
Quarterly Report for period ending 2022-06-30
10-Q
Thursday, 5/12/2022
Quarterly Report for period ending 2022-03-31
10-K
Wednesday, 3/30/2022
Annual Report for period ending 2021-12-31
10-Q
Monday, 11/15/2021
Quarterly Report for period ending 2021-09-30
10-Q
Monday, 8/16/2021
Quarterly Report for period ending 2021-06-30
10-Q
Thursday, 5/13/2021
Quarterly Report for period ending 2021-03-31
10-K
Tuesday, 3/30/2021
Annual Report for period ending 2020-12-31
10-Q
Tuesday, 11/10/2020
Quarterly Report for period ending 2020-09-30
10-K/A
Friday, 9/11/2020
Annual Report for period ending 2019-12-31
10-Q
Tuesday, 8/11/2020
Quarterly Report for period ending 2020-06-30
10-Q
Tuesday, 5/12/2020
Quarterly Report for period ending 2020-03-31
10-K
Thursday, 3/19/2020
Annual Report for period ending 2019-12-31
10-Q
Thursday, 11/14/2019
Quarterly Report for period ending 2019-09-30
10-Q
Thursday, 8/8/2019
Quarterly Report for period ending 2019-06-30
10-Q
Thursday, 5/9/2019
Quarterly Report for period ending 2019-03-31
10-K
Thursday, 3/28/2019
Annual Report for period ending 2018-12-31
10-Q
Thursday, 11/8/2018
Quarterly Report for period ending 2018-09-30
Show More

News (79)

8-K
Tuesday, 2/13/2024
Current report filing
8-K
Wednesday, 1/17/2024
Current report filing
8-K
Wednesday, 12/20/2023
Current report filing
8-K
Monday, 11/27/2023
Current report filing
8-K
Monday, 11/6/2023
Current report filing
8-K
Friday, 10/20/2023
Current report filing
8-K
Friday, 10/13/2023
Current report filing
8-K
Friday, 9/29/2023
Current report filing
8-K
Friday, 9/22/2023
Current report filing
8-K
Tuesday, 9/5/2023
Current report filing
8-K
Friday, 8/25/2023
Current report filing
8-K
Friday, 8/18/2023
Current report filing
8-K
Monday, 8/14/2023
Current report filing
8-K
Wednesday, 8/2/2023
Current report filing
8-K
Friday, 6/16/2023
Current report filing
8-K
Friday, 6/2/2023
Current report filing
8-K
Thursday, 5/11/2023
Current report filing
8-K
Monday, 3/20/2023
Current report filing
8-K
Friday, 3/10/2023
Current report filing
8-K
Monday, 1/9/2023
Current report filing
8-K
Thursday, 11/10/2022
Current report filing
8-K
Tuesday, 10/18/2022
Current report filing
8-K
Thursday, 8/11/2022
Current report filing
8-K
Thursday, 8/4/2022
Current report filing
8-K
Thursday, 7/7/2022
Current report filing
8-K
Friday, 6/17/2022
Current report filing
8-K
Thursday, 5/12/2022
Current report filing
8-K
Monday, 4/11/2022
Current report filing
8-K
Wednesday, 4/6/2022
Current report filing
8-K
Monday, 4/4/2022
Current report filing
8-K
Wednesday, 3/30/2022
Current report filing
8-K
Wednesday, 1/19/2022
Current report filing
8-K
Tuesday, 1/18/2022
Current report filing
8-K
Wednesday, 11/17/2021
Current report filing
8-K
Monday, 11/15/2021
Current report filing
8-K
Wednesday, 11/10/2021
Current report filing
8-K
Tuesday, 10/12/2021
Current report filing
8-K
Wednesday, 10/6/2021
Current report filing
8-K
Monday, 9/27/2021
Current report filing
8-K
Wednesday, 9/8/2021
Current report filing
8-K
Wednesday, 9/8/2021
Current report filing
8-K
Thursday, 9/2/2021
Current report filing
8-K
Monday, 8/16/2021
Current report filing
8-K
Wednesday, 6/30/2021
Current report filing
8-K
Monday, 6/21/2021
Current report filing
8-K
Tuesday, 6/1/2021
Current report filing
8-K
Thursday, 5/13/2021
Current report filing
8-K
Tuesday, 3/30/2021
Current report filing
8-K
Tuesday, 3/9/2021
Current report filing
8-K
Monday, 1/25/2021
Current report filing
8-K
Tuesday, 12/29/2020
Current report filing
8-K
Monday, 12/21/2020
Current report filing
8-K
Tuesday, 11/10/2020
Current report filing
8-K
Tuesday, 8/11/2020
Current report filing
8-K
Friday, 7/31/2020
Current report filing
8-K
Wednesday, 7/15/2020
Current report filing
8-K
Monday, 7/13/2020
Current report filing
8-K
Wednesday, 5/27/2020
Current report filing
8-K
Tuesday, 5/12/2020
Current report filing
8-K
Monday, 3/23/2020
Current report filing
8-K
Wednesday, 3/18/2020
Current report filing
8-K
Wednesday, 3/11/2020
Current report filing
8-K
Friday, 12/20/2019
Current report filing
8-K
Thursday, 11/14/2019
Current report filing
8-K
Friday, 9/27/2019
Current report filing
8-K
Wednesday, 9/4/2019
Current report filing
8-K
Thursday, 8/8/2019
Current report filing
8-K
Monday, 7/29/2019
Current report filing
8-K
Wednesday, 6/19/2019
Current report filing
8-K
Thursday, 6/6/2019
Current report filing
8-K
Tuesday, 5/21/2019
Current report filing
8-K
Thursday, 5/9/2019
Current report filing
8-K
Tuesday, 5/7/2019
Current report filing
8-K
Thursday, 4/11/2019
Current report filing
8-K
Friday, 4/5/2019
Current report filing
8-K
Thursday, 3/28/2019
Current report filing
8-K
Thursday, 12/27/2018
Current report filing
8-K
Tuesday, 12/4/2018
Current report filing
8-K
Thursday, 11/8/2018
Current report filing
Show More

Other (40)

25-NSE
Monday, 11/20/2023
Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
144
Wednesday, 10/18/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 9/25/2023
Filing for proposed sale of securities under Rule 144
D
Thursday, 8/31/2023
Exempt (Private) Offering
144
Wednesday, 8/30/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 8/30/2023
Filing for proposed sale of securities under Rule 144
EFFECT
Tuesday, 8/29/2023
Notice of Effectiveness
CORRESP
Friday, 8/25/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
144
Thursday, 8/24/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 8/24/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 8/24/2023
Filing for proposed sale of securities under Rule 144
CORRESP
Thursday, 7/27/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 5/25/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
ARS
Monday, 4/24/2023
Annual report to security holders
CT ORDER
Wednesday, 3/8/2023
Order Granting Confidential Treatment
EFFECT
Monday, 2/6/2023
Notice of Effectiveness
CORRESP
Thursday, 2/2/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Friday, 8/26/2022
Notice of Effectiveness
CORRESP
Wednesday, 8/24/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Thursday, 12/9/2021
Notice of Effectiveness
CORRESP
Tuesday, 12/7/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 9/4/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Wednesday, 2/12/2020
Notice of Effectiveness
CORRESP
Monday, 2/10/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Wednesday, 1/8/2020
Notice of Effectiveness
CORRESP
Monday, 1/6/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CT ORDER
Thursday, 10/18/2018
Order Granting Confidential Treatment
8-A12B
Thursday, 10/18/2018
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CERT
Thursday, 10/18/2018
Certification by an exchange approving securities for listing
EFFECT
Wednesday, 10/17/2018
Notice of Effectiveness
CORRESP
Wednesday, 10/17/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 10/16/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 10/16/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 10/12/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 10/12/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 10/5/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 10/5/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 9/27/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 9/24/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 9/19/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Show More

Ownership (120)

SC 13D/A
Tuesday, 11/28/2023
Athyrium Opportunities IV Acquisition 2 LP: Major Shareholders
SC 13D/A
Wednesday, 11/1/2023
Altchem Ltd: Major Shareholders
4
Monday, 10/23/2023
Altchem Ltd: Statement of changes in beneficial ownership of securities
4
Monday, 10/23/2023
Harsaul Foundation: Statement of changes in beneficial ownership of securities
4
Friday, 10/20/2023
Harsaul Foundation: Statement of changes in beneficial ownership of securities
4
Friday, 10/20/2023
Altchem Ltd: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 10/13/2023
Athyrium Opportunities IV Acquisition 2 LP: Major Shareholders
SC 13D
Tuesday, 9/5/2023
Athyrium Opportunities IV Acquisition 2 LP: Major Shareholders
4
Thursday, 8/17/2023
Avista Healthcare Partners, L.P.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 8/17/2023
Avista Healthcare Partners GP, Ltd.: Major Shareholders
4
Monday, 8/14/2023
Lask Alisa: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/11/2023
DeBiasi Michael J.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/11/2023
Lask Alisa: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/11/2023
COWAN GREGORY L: Statement of changes in beneficial ownership of securities
4
Monday, 5/22/2023
Schaub James: Statement of changes in beneficial ownership of securities
4
Monday, 5/22/2023
Klein Christopher: Statement of changes in beneficial ownership of securities
4
Monday, 1/30/2023
Burgstahler David F: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 1/30/2023
Avista Healthcare Partners GP, Ltd.: Major Shareholders
4
Monday, 1/30/2023
Avista Capital Partners III GP, L.P.: Statement of changes in beneficial ownership of securities
4
Monday, 1/30/2023
Venkataraman Sriram: Statement of changes in beneficial ownership of securities
4
Thursday, 1/26/2023
Klein Christopher: Statement of changes in beneficial ownership of securities
4
Thursday, 1/26/2023
Schaub James: Statement of changes in beneficial ownership of securities
3
Friday, 8/12/2022
Ferrell Jeffrey: Initial statement of beneficial ownership of securities
3
Friday, 8/12/2022
Lask Alisa: Initial statement of beneficial ownership of securities
4
Friday, 8/12/2022
Lask Alisa: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 8/11/2022
Athyrium Opportunities IV Acquisition 2 LP: Major Shareholders
4
Tuesday, 8/9/2022
Schaub James: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/9/2022
Burgstahler David F: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/9/2022
MARKISON BRIAN A: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/9/2022
Avista Capital Partners III GP, L.P.: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 8/9/2022
Avista Capital Partners III GP, L.P.: Major Shareholders
4
Tuesday, 8/9/2022
Venkataraman Sriram: Statement of changes in beneficial ownership of securities
4
Friday, 5/20/2022
deVries Tina Marie: Statement of changes in beneficial ownership of securities
4
Friday, 5/20/2022
Schaub James: Statement of changes in beneficial ownership of securities
4
Friday, 5/20/2022
Klein Christopher: Statement of changes in beneficial ownership of securities
3
Friday, 4/22/2022
DePetris Michael: Initial statement of beneficial ownership of securities
4
Wednesday, 1/26/2022
Einhorn Andrew J.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/26/2022
deVries Tina Marie: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/26/2022
Klein Christopher: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/26/2022
Schaub James: Statement of changes in beneficial ownership of securities
4
Monday, 12/20/2021
Schaub James: Statement of changes in beneficial ownership of securities
4
Monday, 11/8/2021
Schaub James: Statement of changes in beneficial ownership of securities
4
Monday, 11/8/2021
Klein Christopher: Statement of changes in beneficial ownership of securities
4
Monday, 11/8/2021
deVries Tina Marie: Statement of changes in beneficial ownership of securities
4
Monday, 11/8/2021
MARKISON BRIAN A: Statement of changes in beneficial ownership of securities
4
Monday, 11/8/2021
Einhorn Andrew J.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 11/3/2021
Altchem Ltd: Major Shareholders
SC 13G
Friday, 10/22/2021
Athyrium Opportunities IV Acquisition 2 LP: Major Shareholders
SC 13D/A
Thursday, 10/14/2021
Avista Capital Partners III GP, L.P.: Major Shareholders
4
Friday, 9/3/2021
WEISS FRED G: Statement of changes in beneficial ownership of securities
4
Friday, 9/3/2021
COWAN GREGORY L: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/7/2021
WEISS FRED G: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/22/2021
WEISS FRED G: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/22/2021
COWAN GREGORY L: Statement of changes in beneficial ownership of securities
4
Thursday, 5/20/2021
Klein Christopher: Statement of changes in beneficial ownership of securities
4
Thursday, 5/20/2021
Schaub James: Statement of changes in beneficial ownership of securities
4
Thursday, 5/20/2021
deVries Tina Marie: Statement of changes in beneficial ownership of securities
4
Thursday, 5/20/2021
Einhorn Andrew J.: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 4/29/2021
Orbit Co-Invest I LLC: Major Shareholders
4
Tuesday, 1/26/2021
COWAN GREGORY L: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/26/2021
Einhorn Andrew J.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/26/2021
WEISS FRED G: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/26/2021
deVries Tina Marie: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/26/2021
Schaub James: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/26/2021
Klein Christopher: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 11/27/2020
Orbit Co-Invest I LLC: Major Shareholders
4
Monday, 11/23/2020
Venkataraman Sriram: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 11/23/2020
Avista Capital Partners III GP, L.P.: Major Shareholders
4
Monday, 11/23/2020
Avista Healthcare Partners GP, Ltd.: Statement of changes in beneficial ownership of securities
4
Monday, 11/23/2020
Burgstahler David F: Statement of changes in beneficial ownership of securities
4
Friday, 5/22/2020
COWAN GREGORY L: Statement of changes in beneficial ownership of securities
4
Friday, 5/22/2020
WEISS FRED G: Statement of changes in beneficial ownership of securities
4
Friday, 5/22/2020
MARKISON BRIAN A: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/20/2020
Einhorn Andrew J.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/20/2020
Klein Christopher: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/20/2020
deVries Tina Marie: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/20/2020
Schaub James: Statement of changes in beneficial ownership of securities
4
Thursday, 1/30/2020
WEISS FRED G: Statement of changes in beneficial ownership of securities
4
Thursday, 1/30/2020
Einhorn Andrew J.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/30/2020
Klein Christopher: Statement of changes in beneficial ownership of securities
4
Thursday, 1/30/2020
deVries Tina Marie: Statement of changes in beneficial ownership of securities
4
Thursday, 1/30/2020
COWAN GREGORY L: Statement of changes in beneficial ownership of securities
4
Thursday, 1/30/2020
Schaub James: Statement of changes in beneficial ownership of securities
SC 13D
Thursday, 1/23/2020
Avista Capital Partners III GP, L.P.: Major Shareholders
SC 13D
Wednesday, 1/22/2020
Altchem Ltd: Major Shareholders
4
Wednesday, 1/15/2020
Venkataraman Sriram: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/15/2020
Harsaul Foundation: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/15/2020
Burgstahler David F: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/15/2020
Altchem Ltd: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/15/2020
Avista Capital Partners III GP, L.P.: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/1/2019
DeBiasi Michael J.: Initial statement of beneficial ownership of securities
4
Wednesday, 6/19/2019
COWAN GREGORY L: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/19/2019
WEISS FRED G: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/27/2019
MARKISON BRIAN A: Statement of changes in beneficial ownership of securities
SC 13G
Thursday, 2/14/2019
Altchem Ltd: Major Shareholders
SC 13G
Thursday, 2/7/2019
Avista Capital Partners III GP, L.P.: Major Shareholders
4
Monday, 1/28/2019
Klein Christopher: Statement of changes in beneficial ownership of securities
4
Monday, 1/28/2019
WEISS FRED G: Statement of changes in beneficial ownership of securities
4
Monday, 1/28/2019
Schaub James: Statement of changes in beneficial ownership of securities
4
Monday, 1/28/2019
deVries Tina Marie: Statement of changes in beneficial ownership of securities
Show More

Prospectus (28)

S-3
Wednesday, 8/23/2023
Registration statement for specified transactions by certain issuers
424B5
Thursday, 8/17/2023
Prospectus filed pursuant to Rule 424(b)(5)
S-3
Friday, 1/27/2023
Registration statement for specified transactions by certain issuers
S-3
Friday, 8/19/2022
Registration statement for specified transactions by certain issuers
S-8
Tuesday, 11/16/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-3
Wednesday, 10/27/2021
Registration statement for specified transactions by certain issuers
424B5
Friday, 10/8/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Wednesday, 10/6/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Wednesday, 9/8/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B3
Friday, 12/4/2020
Prospectus filed pursuant to Rule 424(b)(3)
424B5
Wednesday, 7/15/2020
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 7/14/2020
Prospectus filed pursuant to Rule 424(b)(5)
S-3
Friday, 1/31/2020
Registration statement for specified transactions by certain issuers
424B4
Friday, 1/10/2020
Prospectus filed pursuant to Rule 424(b)(4)
S-1/A
Monday, 1/6/2020
General form of registration statement for all companies including face-amount certificate companies
S-1
Friday, 12/20/2019
General form of registration statement for all companies including face-amount certificate companies
S-8
Monday, 10/29/2018
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Friday, 10/19/2018
Prospectus filed pursuant to Rule 424(b)(4)
FWP
Thursday, 10/18/2018
Filing under Securities Act Rules 163/433 of free writing prospectuses
S-1/A
Wednesday, 10/17/2018
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Monday, 10/1/2018
General form of registration statement for all companies including face-amount certificate companies
S-1
Friday, 9/14/2018
General form of registration statement for all companies including face-amount certificate companies
DRS/A
Wednesday, 8/22/2018
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Wednesday, 8/22/2018
Correspondence Related to Draft Registration Statement
DRS/A
Friday, 7/13/2018
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS/A
Wednesday, 6/20/2018
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Wednesday, 6/20/2018
Correspondence Related to Draft Registration Statement
DRS
Wednesday, 5/9/2018
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Show More

Proxies (22)

DEF 14A
Thursday, 11/16/2023
Definitive proxy statements
PRE 14A
Monday, 11/6/2023
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEF 14A
Tuesday, 9/5/2023
Definitive proxy statements
PRE 14A
Friday, 8/25/2023
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEFA14A
Monday, 4/24/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Monday, 4/24/2023
Definitive proxy statements
PRE 14A
Wednesday, 4/12/2023
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEFA14A
Wednesday, 6/1/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Monday, 4/25/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Monday, 4/25/2022
Definitive proxy statements
PRE 14A
Tuesday, 4/12/2022
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEF 14A
Wednesday, 12/8/2021
Definitive proxy statements
DEFA14A
Wednesday, 5/19/2021
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Wednesday, 4/28/2021
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Monday, 4/26/2021
Definitive proxy statements
PRE 14A
Friday, 4/9/2021
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEF 14A
Monday, 4/20/2020
Definitive proxy statements
PRE 14A
Wednesday, 4/8/2020
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEF 14A
Monday, 8/12/2019
Definitive proxy statements
PRE 14A
Thursday, 6/27/2019
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEFA14A
Friday, 4/26/2019
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Friday, 4/26/2019
Definitive proxy statements
Show More